These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27578104)

  • 21. Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries.
    Futema M; Ramaswami U; Tichy L; Bogsrud MP; Holven KB; Roeters van Lennep J; Wiegman A; Descamps OS; De Leener A; Fastre E; Vrablik M; Freiberger T; Esterbauer H; Dieplinger H; Greber-Platzer S; Medeiros AM; Bourbon M; Mollaki V; Drogari E; Humphries SE
    Atherosclerosis; 2021 Feb; 319():108-117. PubMed ID: 33508743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing.
    Razman AZ; Chua YA; Mohd Kasim NA; Al-Khateeb A; Sheikh Abdul Kadir SH; Jusoh SA; Nawawi H;
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis.
    Di Costanzo A; Minicocci I; D'Erasmo L; Commodari D; Covino S; Bini S; Ghadiri A; Ceci F; Maranghi M; Catapano AL; Gazzotti M; Casula M; Montali A; Arca M
    J Clin Lipidol; 2021; 15(6):822-831. PubMed ID: 34756585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Familial hypercholesterolemia in Tunisia].
    Jelassi A; Jguirim I; Najah M; Maatouk F; Ben Hamda K; Slimane MN
    Pathol Biol (Paris); 2009 Jul; 57(5):444-50. PubMed ID: 19041195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
    Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
    Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population.
    Fairoozy RH; Futema M; Vakili R; Abbaszadegan MR; Hosseini S; Aminzadeh M; Zaeri H; Mobini M; Humphries SE; Sahebkar A
    Sci Rep; 2017 Dec; 7(1):17087. PubMed ID: 29213121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia.
    Alves AC; Etxebarria A; Soutar AK; Martin C; Bourbon M
    Hum Mol Genet; 2014 Apr; 23(7):1817-28. PubMed ID: 24234650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.
    Martin R; Latten M; Hart P; Murray H; Bailie DA; Crockard M; Lamont J; Fitzgerald P; Graham CA
    Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico.
    Robles-Osorio L; Huerta-Zepeda A; Ordóñez ML; Canizales-Quinteros S; Díaz-Villaseñor A; Gutiérrez-Aguilar R; Riba L; Huertas-Vázquez A; Rodríguez-Torres M; Gómez-Díaz RA; Salinas S; Ongay-Larios L; Codiz-Huerta G; Mora-Cabrera M; Mehta R; Gómez Pérez FJ; Rull JA; Rabès JP; Tusié-Luna MT; Durán-Vargas S; Aguilar-Salinas CA
    Arch Med Res; 2006 Jan; 37(1):102-8. PubMed ID: 16314194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Array-based resequencing for mutations causing familial hypercholesterolemia.
    Chiou KR; Charng MJ; Chang HM
    Atherosclerosis; 2011 Jun; 216(2):383-9. PubMed ID: 21376320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
    Reddy LL; Shah SAV; Ashavaid TF
    Indian Heart J; 2022; 74(1):1-6. PubMed ID: 34875256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis.
    Di Taranto MD; D'Agostino MN; Fortunato G
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):979-87. PubMed ID: 26165249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
    Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
    J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.
    Abifadel M; Rabès JP; Jambart S; Halaby G; Gannagé-Yared MH; Sarkis A; Beaino G; Varret M; Salem N; Corbani S; Aydénian H; Junien C; Munnich A; Boileau C
    Hum Mutat; 2009 Jul; 30(7):E682-91. PubMed ID: 19319977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes.
    Damgaard D; Jensen JM; Larsen ML; Soerensen VR; Jensen HK; Gregersen N; Jensen LG; Faergeman O
    Atherosclerosis; 2004 Dec; 177(2):415-22. PubMed ID: 15530918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and molecular architecture of familial hypercholesterolemia.
    Abifadel M; Boileau C
    J Intern Med; 2023 Feb; 293(2):144-165. PubMed ID: 36196022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic spectrum of low density lipoprotein receptor gene variations in South Indian population.
    ArulJothi KN; Suruthi Abirami B; Devi A
    Clin Chim Acta; 2018 Mar; 478():28-36. PubMed ID: 29269200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular genetics of hypercholesterolemia].
    Schwarzová L
    Vnitr Lek; 2016; 62(11):877-881. PubMed ID: 28128573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.